The influence of SARS-CoV-2 vaccine and SARS-CoV-2 infection on the outcomes of IVF-ET

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055721

Enrollment

Unknown

Registered

2022-01-16

Start date

2021-01-01

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

SARS-CoV-2 vaccine and uninfected by SARS-CoV-2:Nil

no SARS-CoV-2 vaccine and infection:Nil

SARS-CoV-2 vaccine and infected by SARS-CoV-2:Nil

no SARS-CoV-2 vaccine and infected by SARS-CoV-2:Nil

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: IVF-ET cycle.

Exclusion criteria

Exclusion criteria: oocyte and sperm donation cycle

Design outcomes

Primary

Measure	Time frame
embryo formation rate;	—

Secondary

Measure	Time frame
Number of oocytes retrieved;oocyte maturation rate;normal fertilized oocytes;high quality D3 embryo formation rate;blastocyst formation rate;high quality blastocyst rate;embryo implantation rate;clinical pregnancy rate;abortion rate;	—

Countries

China

Contacts

Public ContactGong Yan

Sichuan Provincial Women’s and Children's Hospital

gongyan_496181657@qq.com+86 15208393996

Outcome results